TY - JOUR
T1 - Correction
T2 - Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma (Journal of Biological Chemistry (2019) 294 (11286–11296) DOI: 10.1074/jbc.RA119.009494)
AU - Ryan, Jeremy J.
AU - Sprunger, Macy L.
AU - Holthaus, Kayla
AU - Shorter, James
AU - Jackrel, Meredith E.
N1 - Publisher Copyright:
© 2019 Ryan et al.
PY - 2019/11/15
Y1 - 2019/11/15
N2 - Throughout the text, the abbreviations “EWS-FLI1” and “EWS-FLI3” refer to EWS-FLI1, type 1 and EWS-FLI1, type 3, respectively. These are EWS-FLI1 fusion proteins that arise from slightly different chromosomal translocations that are found naturally in human sarcomas (1). Domain maps for these distinct fusion proteins are shown in Fig. 2A.
AB - Throughout the text, the abbreviations “EWS-FLI1” and “EWS-FLI3” refer to EWS-FLI1, type 1 and EWS-FLI1, type 3, respectively. These are EWS-FLI1 fusion proteins that arise from slightly different chromosomal translocations that are found naturally in human sarcomas (1). Domain maps for these distinct fusion proteins are shown in Fig. 2A.
UR - http://www.scopus.com/inward/record.url?scp=85075114835&partnerID=8YFLogxK
U2 - 10.1074/jbc.AAC119.011523
DO - 10.1074/jbc.AAC119.011523
M3 - Comment/debate
C2 - 31732685
AN - SCOPUS:85075114835
SN - 0021-9258
VL - 294
SP - 17707
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 46
ER -